Cancer-Causing Gut Bacteria

Mice with inflammatory bowel disease harbor gut bacteria that damage host DNA, predisposing mice to cancer.

Written byEdyta Zielinska
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A usually benign strain of the gut microbe E. coli produces toxins in mice with inflammatory bowel disease, which can lead to DNA-damage and cancer in the host tissue. The results were reported last week in Science (August 16).

“They're not exactly your flagship disease-causing bacteria,” lead researcher Christian Jobin, from the University of North Carolina at Chapel Hill, told Nature.

Individuals with inflammatory bowel disease are at higher risk of developing colorectal cancer than the general population. But researchers thought that the main culprit was the over-active immune cells, which released DNA-damaging molecules. The new work suggests that gut microbes may also contribute to the process, as inflammation appears to change the microbial composition of the gut to favor toxin-producing E. coli strains.

Experts think that the research could lead to methods of reducing the risk of cancer by altering the microbial community, though that strategy has to be ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies